Alector, Inc. Announces Results of 2026 Annual Meeting of Stockholders

On June 17, 2026, Alector, Inc. held its 2026 Annual Meeting of Stockholders to vote on three key proposals. Stockholders elected three Class II director nominees—Elizabeth Garofalo, M.D., Errol De Souza, Ph.D., and Kristine Yaffe, M.D.—to serve until the 2029 annual meeting. Additionally, the appointment of Ernst & Young LLP as the company's independent registered accounting firm for the fiscal year ending December 31, 2026, was ratified with an overwhelming majority of 97,717,750 votes in favor. Finally, stockholders approved, on a non-binding advisory basis, the compensation of the company's named executive officers (the 'Say-on-Pay' vote). All proposals passed according to the certified results, with significant participation from the company's common stock holders. The meeting results ensure the continuation of the current board structure and independent auditing oversight for the upcoming fiscal year. No clinical trial updates or material business changes were reported in this filing.